(2S,3R,4S,6R)-4-(dimethylamino)-2-(((3R,4S,5S,6R,7R,9R,11R,12S,13R,14R)-14-ethyl-7,12-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl)oxy)-6-methyltetrahydro-2H-pyran-3-yl ethyl succinate
Erythromycin B ethylsuccinate is a fully characterized chemical compound used as a reference standard of API Erythromycin. The standard offered is compliant with regulatory guidelines. Erythromycin B ethylsuccinate is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS -
Related products
Erythromycin Impurity J (Roxithromycin EP Impurity C)
M.F.
M.W. 748.95
CAT# AR-E01801
CAS# 111321-02-9
Erythromycin EP Impurity E (Erythromycin A Enol Ether)
M.F.
M.W. 715.92
CAT# AR-E01814
CAS# 33396-29-1
2’,4’’-O-Bis(trimethylsilyl)-6-O-methylerythromycin A 9-[O-(1- methoxy-1-methylethyl) Oxime
M.F.
M.W. 979.45
CAT# AR-E01831
CAS# 119699-81-9
